Office of the Vice President for Global Communications

Monday, June 21, 2010

Alonzo Fulgham (center), chief operating officer of the U.S. Agency for International Development, visits with Robert Dolan (left), Edward J. Frey Dean of Business at the Stephen M. Ross School of Business, and Bob Kennedy, director of the Ross School’s William Davidson Institute. The Davidson Institute hosted a luncheon in Washington, D.C., last week at which Fulgham said it is hoped the American higher education community can partner with the government to help solve development problems in needy countries around the world. Click here for more on Fulgham’s remarks. (Photo by Mike Waring, U-M Washington Office)

Active U continues to grow; 18 million activity minutes logged
Active U’s fifth year proved to be the program’s biggest, with more than 11,300 university faculty and staff logging more than 18 million physical-activity minutes — nearly 2,000 more participants and two million more minutes than last year.

Resurfaced Washington Street to aid Summer Festival, move-in at North Quad complex
U-M has resurfaced Washington Street from Fletcher to State streets. Completed at no cost to the City of Ann Arbor, the resurfacing work will provide smooth egress for the North Quad move-in, which starts in August, as well as a smoother “dance floor” for visitors to the Ann Arbor Summer Festival’s Top of the Park entertainment series at Ingalls Mall.

MHealthy offering free tobacco treatment programs for employees
MHealthy is offering seven-week Kick the Habit programs to help people quit smoking. The sessions are free to U-M employees and patients with a U-M physician referral. The next program starts July 7. Click here to learn about other tobacco-cessation programs for employees.

The Michigan Difference

Personalized medicine
Seeking to understand why people react differently to a particular medication or dosage, scientists now are focusing on pharmacogenomics, the study of how a person's genome affects response to a specific drug. Vicki Ellingrod, associate professor of pharmacy and psychiatry, heads up the Clinical Pharmacogenomics Laboratory where she has studied the risk factors of metabolic syndrome, a major side effect for people taking schizophrenia drugs.